文献速递眼整形与眼眶神经眼科眼外伤

眼眶手术后失明的发生率、危险因素与管理

Incidence, Risk Factors, and Management of Blindness after Orbital Surgery.
PubMed 文献 · Ophthalmology · 2018-03-15

这项回顾性研究分析了1994年1月至2014年12月两家学术医疗中心1665例眼眶手术患者,严重视力丧失总体风险为0.84%,在多发性面部骨折眼眶底修复、视神经管骨性减压及经颅内入路眶顶手术的亚组中风险更高,部分可逆原因患者经紧急再手术后视力恢复。

要点

  • 眼眶手术后严重视力丧失的总体风险为0.84%(14/1665)。
  • 多发性面部骨折眼眶底修复亚组风险为6.45%,视神经管骨性减压为15.6%,经颅内入路眶顶为18.2%。
  • 静脉注射皮质类固醇对视力结局无显著影响。

核心结论

  • 眼眶手术后严重视力丧失的总体风险为0.84%。
  • 多发性面部创伤修复、视神经管减压或经颅内入路眶尖手术的患者亚组风险更高。
  • 密切的术后监测以及对急性视力丧失的紧急评估和处理可能改善部分患者的视力结局。

研究设计与样本

  • 回顾性综述,纳入1994年1月至2014年12月期间在两家学术医疗中心接受眼眶手术的患者,共1665例。

主要发现

  • 14例患者发生严重视力丧失,范围从1英尺数指到无光感,总体风险为0.84%。
  • 视力丧失的原因包括球后出血、植入物位置不当、视神经缺血或视神经直接损伤。
  • 按手术入路分层,多发性面部骨折眼眶底修复亚组风险为6.45%,视神经管骨性减压亚组风险为15.6%,经颅内入路眶顶亚组风险为18.2%。
  • 8例术后视力丧失可能可逆的患者中7例接受了紧急再手术,其中2例视力大幅恢复(20/20和20/25)。
  • 静脉注射皮质类固醇对视力 acuity 结局无显著影响。

关键数值与推荐

  • 术前视力≥20/200且眼眶手术后视力恶化至≤20/400的患者被纳入详细审查。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Severe vision loss is a risk of orbital surgery which physicians should counsel patients about, but the overall risk rate is unknown. This research was conducted to determine the risk of severe vision loss related to orbital surgery. DESIGN: Retrospective review. PARTICIPANTS: Patients who underwent orbital surgery at either of 2 academic medical centers between January 1994 and December 2014. METHODS: A billing database search was conducted to identify all patients who had orbital surgery during the study period, cross-checked against diagnostic codes related to vision loss. Charts were screened to determine baseline demographic and medical history, surgical procedure, intraoperative and perioperative management, and visual acuity. Patients with preoperative visual acuity ≥20/200 that worsened ≤20/400 after orbital surgery were included for detailed review. Statistical analysis was conducted to identify factors posing particular risk or benefit to visual outcome in these patients. MAIN OUTCOME MEASURES: Visual acuity after orbital surgery. RESULTS: A total of 1665 patients underwent orbital surgery during the inclusion period, with 14 patients sustaining severe vision loss ranging from counting fingers at 1 foot to no light perception (overall risk, 0.84%). The causes of vision loss included retrobulbar hemorrhage, malpositioned implant, optic nerve ischemia, or direct optic nerve insult. When stratified by surgical approach, the risk of a blinding surgical complication was significantly higher for patients undergoing orbital floor repair in the setting of multiple facial fractures (subgroup risk, 6.45%), bony decompression of the optic canal (subgroup risk, 15.6%), or intracranial approach to the orbital roof (subgroup risk, 18.2%). Seven of 8 patients with a potentially reversible cause of postoperative vision loss underwent urgent repeat surgery, and 2 regained substantial vision (20/20 and 20/25). Administration of intravenous corticosteroids had no significant effect on visual acuity outcome. CONCLUSIONS: The overall risk of severe vision loss after orbital surgery is 0.84%. The subgroup risk is higher in patients undergoing facial polytrauma repair, optic canal decompression, or orbital apex surgery from an intracranial approach. Close postoperative monitoring and urgent assessment and management of acute vision loss may improve visual outcome in some patients.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Jacobs SM, McInnis CP, Kapeles M, et al. Incidence, Risk Factors, and Management of Blindness after Orbital Surgery. Ophthalmology. 2018. PMID: 29551422. doi:10.1016/j.ophtha.2018.01.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。